뉴스벤징가
Xenon Stock Reaction Is Overblown: Analyst
· 발표
기사 요약
Xenon Pharmaceuticals submits an FDA application for azetukalner for seizures while voluntarily pausing enrollment in depression trials.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
Xenon Pharmaceuticals submits an FDA application for azetukalner for seizures while voluntarily pausing enrollment in depression trials.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…